0001127602-19-020908.txt : 20190605 0001127602-19-020908.hdr.sgml : 20190605 20190605170919 ACCESSION NUMBER: 0001127602-19-020908 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190603 FILED AS OF DATE: 20190605 DATE AS OF CHANGE: 20190605 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOLDING DAVID W CENTRAL INDEX KEY: 0001286630 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11993 FILM NUMBER: 19880559 MAIL ADDRESS: STREET 1: 1312 OXFORD LANE CITY: GLENVIEW STATE: IL ZIP: 60025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BioScrip, Inc. CENTRAL INDEX KEY: 0001014739 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 050489664 STATE OF INCORPORATION: CO FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1600 BROADWAY STREET 2: SUITE 700 CITY: DENVER STATE: CO ZIP: 80202 BUSINESS PHONE: 720 697 5200 MAIL ADDRESS: STREET 1: 1600 BROADWAY STREET 2: SUITE 700 CITY: DENVER STATE: CO ZIP: 80202 FORMER COMPANY: FORMER CONFORMED NAME: MIM CORP DATE OF NAME CHANGE: 19960516 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2019-06-03 0001014739 BioScrip, Inc. BIOS 0001286630 GOLDING DAVID W C/O BIOSCRIP INC. 1600 BROADWAY, SUITE 950 DENVER CO 80202 1 Cash-Settled Restricted Stock Unit 2019-06-03 4 A 0 18905 0 A Common Stock, $.0001 Par Value 18905 18905 D Each Cash-Settled Restricted Stock Unit ("Cash-Settled RSU") is the economic equivalent of one share of BioScrip common stock. Upon vesting, each Cash-Settled RSU will entitle the awardee to a cash-payment equal to the "Fair Market Value" (as defined in the Company's 2018 Equity Incentive Plan (the "Plan")) of one share of BioScrip common stock on the vesting date. The Cash-Settled RSUs vest and become non-forfeitable on the earlier of (1) the consummation of a Change of Control (as defined in the Plan), and (2) the day before the Company's 2020 Annual Meeting, provided the awardee has remained in continuous service as a member of the Company's Board of Directors through such date. /s/ David W. Golding 2019-06-05